Matches in Wikidata for { <http://www.wikidata.org/entity/Q80365103> ?p ?o ?g. }
Showing items 1 to 27 of
27
with 100 items per page.
- Q80365103 description "clinical trial" @default.
- Q80365103 description "ensayu clínicu" @default.
- Q80365103 description "klinisch onderzoek" @default.
- Q80365103 description "клінічне випробування" @default.
- Q80365103 name "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 name "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 type Item @default.
- Q80365103 label "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 label "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 prefLabel "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 prefLabel "The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer" @default.
- Q80365103 P1132 Q80365103-D0EA2B1D-9B6D-4B65-B7BA-4744D7A51336 @default.
- Q80365103 P1476 Q80365103-2F26B8C0-2711-4FDD-AF49-5415FE0DE859 @default.
- Q80365103 P2899 Q80365103-8483CCE4-2B0B-4233-BF03-8BF5EED78FE0 @default.
- Q80365103 P3098 Q80365103-ABA12763-F7CA-4BC4-9856-B4BDBC408201 @default.
- Q80365103 P31 Q80365103-4D512862-590A-4A91-8F20-6BEEE47969F4 @default.
- Q80365103 P580 Q80365103-134DBF6B-AA6A-44F5-8FC5-C31D393B5054 @default.
- Q80365103 P582 Q80365103-6F384074-B2CA-4911-98B9-F5A14C632E5D @default.
- Q80365103 P8363 Q80365103-D32E3CCA-80CA-4979-879D-933824AE3F37 @default.
- Q80365103 P1132 "+825" @default.
- Q80365103 P1476 "START: Real-world Study on Sequential Therapy With Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer (NSCLC)" @default.
- Q80365103 P2899 "+18" @default.
- Q80365103 P3098 "NCT04206787" @default.
- Q80365103 P31 Q30612 @default.
- Q80365103 P580 "2019-12-19T00:00:00Z" @default.
- Q80365103 P582 "2023-12-15T00:00:00Z" @default.
- Q80365103 P8363 Q818574 @default.